Clinical Trial Update: Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled trial evaluating ONO-2506PO in patients with amyotrophic lateral sclerosis, studied in the presence of riluzole; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• ONO-2506PO
• Riluzole (riluzole)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED